Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...

More than 52,000 people are diagnosed with prostate cancer every year, making it the most common cancer that affects men.

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, the ...

Being given just six months to live came as a shock to Craig Pankhurst because he assumed not hearing from the doctor about ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Prostate Cancer UK says men at highest risk should be told that they can request a blood test to look for signs of the ...

There is a limit of eight, 30-minute appointments. To schedule an appointment, or inquire further, call the hospital’s social ...